Public Profile

10x Genomics, Inc.

10x Genomics, Inc., a leading biotechnology company headquartered in the United States, was founded in 2012. The company has established itself as a pioneer in the field of genomics, focusing on innovative solutions for single-cell analysis, spatial biology, and gene expression profiling. With a commitment to advancing scientific research, 10x Genomics has developed a suite of unique products, including the Chromium platform, which enables high-throughput genomic analysis with unparalleled resolution. Operating primarily in North America and expanding globally, 10x Genomics has achieved significant milestones, including numerous awards for its cutting-edge technology. The company’s position in the market is bolstered by its robust intellectual property portfolio and collaborations with leading research institutions, making it a key player in the rapidly evolving life sciences industry.

DitchCarbon Score

How does 10x Genomics, Inc.'s carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.

18

Industry Average

Mean score of companies in the Health Services industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.

2

Industry Benchmark

10x Genomics, Inc.'s score of 18 is higher than 84% of the industry. This can give you a sense of how well the company is doing compared to its peers.

84%

10x Genomics, Inc.'s reported carbon emissions

10x Genomics, Inc., headquartered in the US, currently does not have publicly available carbon emissions data or specific reduction targets. Without reported emissions figures, it is unclear how the company is addressing its carbon footprint or what commitments it has made towards climate action. In the absence of concrete data, it is essential to note that many companies in the biotechnology sector are increasingly focusing on sustainability and setting ambitious climate goals. However, without specific information from 10x Genomics, it is not possible to detail their initiatives or achievements in this area.

Industry emissions intensity

Very low
Low
Medium
High
Very high
Some industries are more carbon intensive than others. 10x Genomics, Inc.'s primary industry is Health and social work services (85), which is low in terms of carbon intensity compared to other industries.

Location emissions intensity

Very low
Low
Medium
High
Very high
The carbon intensity of the energy grid powering a company's primary operations has a strong influence on its overall carbon footprint. 10x Genomics, Inc. is headquartered in US, which has a rank of low, indicating low grid carbon intensity.

Reduction initiatives & disclosure networks

Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.

10x Genomics, Inc. is not committed to any reduction initiatives we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.

Science Based Targets Initiative
Carbon Disclosure Project
The Climate Pledge
UN Global Compact
Carbon Disclosure Project
The Climate Pledge
UN Global Compact

Similar Organizations

Olink Proteomics AB

SE
Research and development services (73)
Updated 1 day ago

Broadcom

US
Computer and related services (72)
Updated about 8 hours ago

Oxford Nanopore Technologies

GB
Furniture; other manufactured goods n.e.c. (36)
Updated 3 days ago

Invitae Corporation

US
Other business services (74)
Updated 3 days ago

Nanostring Technologies

US
Health and social work services (85)
Updated 3 days ago

Standard BioTools Inc.

US
Medical, precision and optical instruments, watches and clocks (33)
Updated 6 days ago

Where does DitchCarbon data come from?

Discover our data-driven methodology for measuring corporate climate action and benchmarking against industry peers